# Cannabidiol for Reducing Drinking in Alcohol Use Disorder

> **NCT05159830** · PHASE2 · RECRUITING · sponsor: **Hôpital le Vinatier** · enrollment: 76 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Cannabidiol oral oil
- **DRUG:** Placebo oral oil

## Key facts

- **NCT ID:** NCT05159830
- **Lead sponsor:** Hôpital le Vinatier
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-25
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05159830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05159830, "Cannabidiol for Reducing Drinking in Alcohol Use Disorder". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05159830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
